Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Vaccinia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00002916
What this trial is testing

Surgery and Vaccine Therapy in Treating Patients With Early Cervical Cancer

Who this might be right for
Cervical Cancer
European Organisation for Research and Treatment of Cancer - EORTC 44
Testing effectiveness (Phase 2)Looking for participantsNCT03354728
What this trial is testing

Multi-antigen CMV-Modified Vaccinia Ankara Vaccine in Treating Pediatric Patients With Positive Cytomegalovirus Undergoing Donor Stem Cell Transplant

Who this might be right for
Cytomegaloviral InfectionHematopoietic Cell Transplant Recipient
City of Hope Medical Center 80
Testing effectiveness (Phase 2)Study completedNCT05099965
What this trial is testing

Trial to Evaluate the Safety and Immunogenicity of a Modified Vaccinia Ankara (MVA)-Based Anti-Cytomegalovirus (CMV) Vaccine (Triplex®)

Who this might be right for
Cytomegalovirus InfectionsHIV InfectionsVaccine
National Institute of Allergy and Infectious Diseases (NIAID) 94
Not applicableStudy completedNCT01395082
What this trial is testing

ACAM2000® Myopericarditis Registry

Who this might be right for
MyocarditisPericarditis
Emergent BioSolutions 24
Early research (Phase 1)Active Not RecruitingNCT05914376
What this trial is testing

Safety of Recombinant Human IL-21-expressing Oncolytic Vaccinia Virus Injection (hV01) in Advanced Tumors

Who this might be right for
Advanced Solid Tumors
Hangzhou Converd Co., Ltd. 24
Early research (Phase 1)Study completedNCT00000957
What this trial is testing

A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Vaccinia Derived HIV-1 Recombinant Envelope Glycoprotein (gp160) of Human Immunodeficiency Virus: Evaluation of Accelerated Schedules

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 30
Testing effectiveness (Phase 2)Study completedNCT05740982
What this trial is testing

Randomized Multisite Trial to Inform Public Health Strategies Involving the Use of MVA-BN Vaccine for Mpox

Who this might be right for
Monkeypox
National Institute of Allergy and Infectious Diseases (NIAID) 450
Testing effectiveness (Phase 2)Study completedNCT02564523
What this trial is testing

Safety, Tolerability and Immunogenicity Study of 3 Prime-boost Regimens for Ebola Vaccines Ad26.ZEBOV/MVA-BN-Filo in Healthy Adults, Children and Human Immunodeficiency Virus Positive (HIV+) Adults

Who this might be right for
Hemorrhagic Fever, Ebola
Janssen Vaccines & Prevention B.V. 1,075
Testing effectiveness (Phase 2)Study completedNCT01636284
What this trial is testing

A Phase 2a Study of Modified Vaccinia Virus to Treat Sorafenib-naïve Advanced Liver Cancer

Who this might be right for
Hepatocellular Carinoma
Jennerex Biotherapeutics 16
Large-scale testing (Phase 3)Study completedNCT01158157
What this trial is testing

VA-006 Vaccinia Vaccine (ACAM2000) for the Production of VIGIV

Who this might be right for
Smallpox Vaccine Adverse Reaction
Emergent BioSolutions 25
Early research (Phase 1)Looking for participantsNCT07398963
What this trial is testing

Clinical Study of Oncolytic Vaccinia VIrus Delivering Targeted CD19 in Vivo CAR-T/M Therapy for Refractory/Relapsed B-cell Lymphoma

Who this might be right for
Refractory/Relapsed B-cell Lymphoma
Second Affiliated Hospital, Zhejiang University, School of Medicine 48
Testing effectiveness (Phase 2)Study completedNCT00019734
What this trial is testing

Vaccine Therapy in Treating Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT00000968
What this trial is testing

A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Vaccinia-Derived HIV-1 Recombinant Envelope Glycoprotein (gp160)

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 60
Testing effectiveness (Phase 2)WithdrawnNCT03438344
What this trial is testing

Multi-antigen CMV-Modified Vaccinia Ankara Vaccine in Reducing CMV Related Complications in Patients With Blood Cancer Undergoing Donor Stem Cell Transplant

Who this might be right for
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveAcute Lymphoblastic Leukemia in RemissionAcute Myeloid Leukemia in Remission+9 more
City of Hope Medical Center
Testing effectiveness (Phase 2)Study completedNCT03206073
What this trial is testing

A Phase I/II Study of Pexa-Vec Oncolytic Virus in Combination With Immune Checkpoint Inhibition in Refractory Colorectal Cancer

Who this might be right for
Colorectal CancerColorectal CarcinomaColorectal Adenocarcinoma+2 more
National Cancer Institute (NCI) 34
Not applicableStudy completedNCT00000866
What this trial is testing

A Multicenter, Randomized, Placebo-Controlled, Double-Blind Trial to Evaluate the Safety and Immunogenicity of the Therion Recombinant Vaccinia-HIV-1 IIIB ENV/GAG/POL Vaccine (TCB-3B) and MN RGP 120/HIV-1 In Alum.

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 36
Early research (Phase 1)Study completedNCT00051922
What this trial is testing

Development of a New HIV Vaccine

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 24
Not applicableStudy completedNCT00379678
What this trial is testing

Effects of Pimecrolimus on Skin Biopsy Ex-plants From Patients With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
National Jewish Health 28
Early research (Phase 1)Study completedNCT00000683
What this trial is testing

A Phase I Multicenter, Randomized, Double-Blind Trial to Evaluate the Safety and Immunogenicity of Recombinant Vaccinia Virus Expressing the Envelope Glycoproteins of Human Immunodeficiency Virus

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 54
Early research (Phase 1)Study completedNCT00068198
What this trial is testing

Human Immune Responses Smallpox

Who this might be right for
Smallpox
National Institute of Allergy and Infectious Diseases (NIAID) 45
Next Page